Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Sponsor: BRIM Biotechnology Inc.
Summary
The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Official title: A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2020-01-15
Completion Date
2020-06-23
Last Updated
2026-05-01
Healthy Volunteers
No
Conditions
Interventions
BRM421
The active control with BRM421 solution
Placebo
The vehicle solution
Locations (4)
Eye Research Foundation
Newport Beach, California, United States
Midwest Cornea Associates, LLC
Indianapolis, Indiana, United States
Andover Eye Associates
Andover, Massachusetts, United States
Total Eye Care
Memphis, Tennessee, United States